LoginSignup
Boston logo

Boston

Stock
Stock
ISIN: US1011371077
Ticker: BSX
US1011371077
BSX

Price

Price

Frequently asked questions

What is Boston's market capitalization?

The market capitalization of Boston is $132.90B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Boston's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Boston is 74.54. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Boston?

Boston's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.21. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Boston's stock?

Currently, 32 analysts cover Boston's stock, with a consensus target price of $82.92. Analyst ratings provide insights into the stock's expected performance.

What is Boston's revenue over the trailing twelve months?

Over the trailing twelve months, Boston reported a revenue of $15.91B.

What is the EBITDA for Boston?

Boston's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $4.63B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Boston?

Boston has a free cash flow of $2.16B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Boston's stock?

The 5-year beta for Boston is 0.80. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Boston have, and what sector and industry does it belong to?

Boston employs approximately 48,000 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Boston's shares?

The free float of Boston is 1.47B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $132.90B

5Y beta

 0.80

EPS (TTM)

 $1.21

Free Float

 1.47B

P/E ratio (TTM)

 74.54

Revenue (TTM)

 $15.91B

EBITDA (TTM)

 $4.63B

Free Cashflow (TTM)

 $2.16B

Pricing

1D span
$89.69$91.74
52W span
$53.93$91.08

Analyst Ratings

The price target is $82.92 and the stock is covered by 32 analysts.

Buy

28

Hold

4

Sell

0

Information

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

48,000

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US1011371077

Primary Ticker

BSX

Knockouts

Join the conversation
Sign upLogin